Skip to main content
C

Cryofocus Medtech (Shanghai) Co., Ltd. — Investor Relations & Filings

Ticker · 6922 HKEX Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2025-08-08 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 6922

About Cryofocus Medtech (Shanghai) Co., Ltd.

http://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co., Ltd. is a medical device company specializing in the research, development, and production of innovative cryoablation systems. The company utilizes self-developed cryotherapy technology primarily in the fields of vascular interventional therapy and procedures via natural cavities. Key products include cryoablation systems designed for the treatment of major diseases such as atrial fibrillation, refractory hypertension, and bladder cancer. Additionally, the product portfolio encompasses surgical consumables and novel endoscopic clips used in digestive tract endoscopic surgery. The company holds independent intellectual property rights for its innovative devices.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025' for Cryofocus Medtech (Shanghai) Co., Ltd. It contains comprehensive unaudited condensed consolidated financial statements, including the statement of profit or loss, statement of financial position, and detailed notes to the financial information. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2025
2025-08-08 English
VOLUNTARY ANNOUNCEMENT NMPA APPROVAL FOR THE REGISTRATION CHANGE OF DISPOSABLE CRYOPROBE OF CRYOADHESION SYSTEM
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement by Cryofocus Medtech to the Hong Kong Exchange regarding NMPA regulatory approval for a product registration change. It is not a financial report, earnings release, AGM material, board change, M&A, or other specific category. There is no attached detailed report; it is a standalone regulatory/business update. This falls under the general “Regulatory Filings” (RNS) category.
2025-08-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2025
Regulatory Filings Classification · 1% confidence The document is a monthly return under HKEX Listing Rules (Form FF301) reporting movements in authorised/registered share capital, issued shares, and related confirmations for the month ended 31 July 2025. It is a routine regulatory submission to the Exchange rather than an announcement of an event (like dividend, share issue, or buyback) or a standalone financial report (like Annual or Interim Report). It does not fit any specific category such as share issuance (SHA) or own share transactions (POS), so the appropriate classification is the general fallback category for miscellaneous regulatory filings: RNS.
2025-08-04 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is not the interim report itself but an announcement of the date of the board meeting to consider and approve the interim results and their publication. It falls under announcements regarding the timing and release of company reports, matching the Report Publication Announcement category.
2025-07-29 English
VOLUNTARY ANNOUNCEMENT BREAKTHROUGH MEDICAL DEVICE DESIGNATION GRANTED BY FDA FOR ASTHMA CRYOABLATION SYSTEM
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement disclosing business development (FDA breakthrough device designation). It does not relate to financial results, board changes, dividends, or securities transactions. It is a general corporate/regulatory announcement that does not fit other specific categories, so it falls into the fallback category Regulatory Filings (RNS).
2025-07-24 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2025
Regulatory Filings Classification · 1% confidence The document is an FF301 form titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B…” detailing monthly movements in registered share capital and issued shares. It is a routine regulatory submission under HKEX Listing Rules rather than a financial report (10-K/IR), earnings release, management announcement, or capital raising notice. This falls under general regulatory filings as there is no specific category for monthly compliance returns. Hence, it is classified as Regulatory Filings (RNS).
2025-07-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.